英语翻译The European UnionOne major difference between U.S.and European policy is that more European nations favor gene therapy.In the final Declaration on Human Cloning vote,the only major Western European nations to vote in favor of it were Ita

英语翻译The European UnionOne major difference between U.S.and European policy is that more European nations favor gene therapy.In the final Declaration on Human Cloning vote,the only major Western European nations to vote in favor of it were Ita
英语翻译
The European Union
One major difference between U.S.and European policy is that more European nations favor gene therapy.In the final Declaration on Human Cloning vote,the only major Western European nations to vote in favor of it were Italy,Ireland,and Portugal,which are more Catholic than many others in the EU.Meanwhile,the United Kingdom,Germany,France,Greece,Belgium,Denmark,Finland,Sweden,and Norway all voted against it,and over half of all opposing nations were European.That being said,these countries are also among the nations that benefit most from the current drug industry,as they can actually afford many of the newer and more expensive drugs tested overseas.On two recently passed European Community Clinical Trials Directives,the body was criticized for narrowing their codes to products for human use,and for generously smoothing over the research approval process and failing to adequately protect patients.This position is not as steadfast as in the United States,however,as critics admit that depending on case law the interpretation of the Directive could change.Thus,it would not be surprising to see European nations attempt to balance both sponsor and community rights,and their ultimate support could heavily influence the outcome of many of these issues.

英语翻译The European UnionOne major difference between U.S.and European policy is that more European nations favor gene therapy.In the final Declaration on Human Cloning vote,the only major Western European nations to vote in favor of it were Ita
欧盟
美国政治和欧洲政治之间的一个主要区别是,更多的欧洲国家青睐基因治疗.在关于克隆人的投票表决的最终结果中,表示支持的主要西方欧洲国家只有意大利,爱尔兰和葡萄牙,支持者在这些国家中比在欧盟中的其他国家中更为普遍.与此同时,英国,德国,法国,希腊,比利时,丹麦,芬兰瑞典和挪威都投票否决,并且超过半数的反对国为欧洲国家.然而,这些国家也属于目前药品工业受益国,他们确实能够支付许多在海外试验的更新更贵的药物.在最近通过的两项临床试验欧洲指令中,这一阵营惨遭批评,因为对人类使用的商品进行规定紧致化,以及对研究和审批过程给予太多慷慨的便利导致未能充分保护病人.这一立场并不如美国坚定,但是,正如批评者所承认的,有关案例法根据该指令的解释可能会改变.因此,欧洲国家都试图平衡赞助商和社区权利并不会让人意外,他们的最终支持将极大地影响其中许多议题的结果.